JNJ-54861911 3 mg

DRUG2 trials

Sponsors

Janssen Research & Development, LLC

Conditions

Healthy

Phase 1

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Volunteers Compared With Placebo

CompletedNCT01827982

Janssen Research & Development, LLCHealthy

Start: 2013-03-31End: 2013-07-31Updated: 2014-11-10

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54861911 in Healthy Elderly Participants

CompletedNCT01887535

Janssen Research & Development, LLCHealthy

Start: 2013-05-31End: 2013-12-31Updated: 2014-01-14